Literature DB >> 24987863

Highly active antiretroviral therapy-related mechanisms of endothelial and platelet function alterations.

Paolo Gresele, Emanuela Falcinelli, Stefania Momi, Daniela Francisci, Franco Baldelli1.   

Abstract

Highly active antiretroviral therapy (HAART) has transformed human immunodeficiency virus (HIV) infection into a chronic condition, which has allowed the infected population to age and become prone to chronic degenerative diseases common to the general population, including atherosclerotic cardiovascular disease, and coronary artery disease (CAD). Possible causative mechanisms of HIV-associated CAD are related to classic cardiovascular risk factors, such as dyslipidemia, insulin resistance, and fat redistribution, which may be due to either HIV infection or to HAART-associated toxicity. However, other mechanisms are emerging as crucial for the cardiovascular complication of HIV and HAART. This article analyzes the effects of HIV and HAART on endothelial function, endothelium-leukocyte interactions, and platelets as possible mechanisms of enhanced cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24987863     DOI: 10.3908.ricm15S1S004

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  10 in total

1.  Elevated homocysteine levels in human immunodeficiency virus-infected patients under antiretroviral therapy: A meta-analysis.

Authors:  Rafael Deminice; Talita Capoani Vieira Silva; Vitor Hugo Fernando de Oliveira
Journal:  World J Virol       Date:  2015-05-12

2.  Risk of cardiovascular disease associated with exposure to abacavir among individuals with HIV: A systematic review and meta-analyses of results from 17 epidemiologic studies.

Authors:  Kunchok Dorjee; Tsering Choden; Sanjiv M Baxi; Craig Steinmaus; Arthur L Reingold
Journal:  Int J Antimicrob Agents       Date:  2018-07-21       Impact factor: 5.283

3.  Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease.

Authors:  Monique E Maubert; Brian Wigdahl; Michael R Nonnemacher
Journal:  Front Neurosci       Date:  2017-04-26       Impact factor: 4.677

4.  Mbarara University Research Training Initiative: a spin-off of the Medical Education Partnership Initiative in Uganda.

Authors:  Edith Wakida; Samuel Maling; Celestino Obua
Journal:  Adv Med Educ Pract       Date:  2017-07-27

5.  Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.

Authors:  Judith M Haissman; Anna K Haugaard; Sisse R Ostrowski; Rolf K Berge; Johannes R Hov; Marius Trøseid; Susanne D Nielsen
Journal:  BMC Infect Dis       Date:  2017-06-23       Impact factor: 3.090

Review 6.  Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets.

Authors:  Morris Madzime; Theresa M Rossouw; Annette J Theron; Ronald Anderson; Helen C Steel
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

7.  Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational Study.

Authors:  Jessie K Edwards; Stephen R Cole; Tiffany L Breger; Jacqueline E Rudolph; Lindsey M Filiatreau; Kate Buchacz; Elizabeth Humes; Peter F Rebeiro; Gypsyamber D'Souza; M John Gill; Michael J Silverberg; W Christopher Mathews; Michael A Horberg; Jennifer Thorne; H Irene Hall; Amy Justice; Vincent C Marconi; Viviane D Lima; Ronald J Bosch; Timothy R Sterling; Keri N Althoff; Richard D Moore; Michael Saag; Joseph J Eron
Journal:  Ann Intern Med       Date:  2021-07-06       Impact factor: 25.391

Review 8.  Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease.

Authors:  Monique E Maubert; Vanessa Pirrone; Nina T Rivera; Brian Wigdahl; Michael R Nonnemacher
Journal:  Front Microbiol       Date:  2016-01-11       Impact factor: 5.640

9.  Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study.

Authors:  Kunchok Dorjee; Sanjiv M Baxi; Arthur L Reingold; Alan Hubbard
Journal:  BMC Infect Dis       Date:  2017-10-27       Impact factor: 3.090

10.  Effect of aspirin on HIV disease progression among HIV-infected individuals initiating antiretroviral therapy: study protocol for a randomised controlled trial.

Authors:  Tosi Mwakyandile; Grace Shayo; Sabina Mugusi; Bruno Sunguya; Philip Sasi; Candida Moshiro; Ferdinand Mugusi; Eligius Lyamuya
Journal:  BMJ Open       Date:  2021-11-02       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.